Journal profile · Pathology
Cardiovascular Pathology
ISSN 1054-8807 · eISSN 1879-1336 · Elsevier Inc. · UNITED STATES · Bimonthly · Founded 1992
Cardiovascular Pathology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.97; hybrid open access; APC about USD 4,210; median 97 days to acceptance (85 articles, last 24 months); community-reported acceptance: about 25%; 68 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Cardiovascular Pathology is published by Elsevier Inc. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Diverse Scientific and Economic Studies, Cardiac tumors and thrombi and Cardiac Valve Diseases and Treatments, together about 22.5% of its articles. Its main subfields are Cardiology and Cardiovascular Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Official Journal of the Society for Cardiovascular PathologyA Journal of Basic, Clinical and Applied Cardiovascular Science, Cardiovascular Pathology is a bimonthly journal that presents articles on topics covering the entire spectrum of cardiovascular disease. The Journal's primary objective is to publish papers on disease-oriented morphology and pathogenesis from clinicians and scientists in the cardiovascular field. Subjects covered include cardiovascular biology, prosthetic devices, molecular biology and experimental models of cardiovascular disease.The Journal publishes articles on all aspects of cardiovascular disease, but with a particular focus on the pathology and pathogenesis of these entities. Authors are invited to submit original research articles. Brief communications, case reports with significant new findings, as well as letters to the Editors will be considered. Review articles may be invited or unsolicited submissions.
From the journal's Aims & Scope
Research area (LetPub): Pathology
Editor-in-chief Joseph MaleszewskiPublisher website
Editorial board by country: 2 in mainland China (about 2%); most named United States 55, Italy 13, Canada 11, Mainland China 2, Switzerland 2 (92 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance8.8%
- Cardiac tumors and thrombiMedicine6.9%
- Cardiac Valve Diseases and TreatmentsMedicine6.8%
- Cardiac Structural Anomalies and RepairMedicine6.8%
- Human auditory perception and evaluationEngineering5.4%
- Cardiac Fibrosis and RemodelingMedicine5.1%
- Infective Endocarditis Diagnosis and ManagementMedicine4.5%
- Viral Infections and Immunology ResearchMedicine4.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Cardiac & Cardiovascular Systems | Zone 4 |
| Minor | Pathology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Cardiac & Cardiovascular Systems | Zone 4 |
| Minor | Pathology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pathology | Zone 3 |
| Minor | Cardiac & Cardiovascular Systems | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.97LetPub ·
- Impact factor (publisher)
- 2Publisher website ·
- CiteScore 2026-06
- 3.8LetPub ·
- CiteScore (publisher)
- 3.8Publisher website ·
- SJR 2026-06
- 0.77LetPub ·
- SNIP 2026-06
- 0.9LetPub ·
- h-index
- 61LetPub ·
- h-index
- 95OpenAlex ·
- i10-index
- 1,121OpenAlex ·
- 2-year mean citedness
- 2.31OpenAlex ·
- Self-citation rate
- 10%LetPub ·
- Share of gold OA articles
- 37.5%LetPub ·
Volume
- Articles per year
- 50LetPub ·
Articles by year OpenAlex count · 3,272 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 35 | 15 | 1 |
| 2025 | 68 | 24 | 97 |
| 2024 | 85 | 44 | 337 |
| 2023 | 51 | 17 | 231 |
| 2022 | 110 | 28 | 624 |
| 2021 | 64 | 20 | 477 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
97 daysMedian, submission to acceptance · P25–P75 65 days – 143 days
- Acceptance to online
- median 2 days (85 articles)
- Submission to online
- median 100 days
- Sample
- 85 articles with submission and acceptance dates (110 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 1 monthLetPub ·
- Average acceptance (community reports)
- 25%LetPub ·
- Submission to first decision
- 5 daysPublisher website ·
- First decision after review
- 27 daysPublisher website ·
- Submission to acceptance
- 100 daysPublisher website ·
- Acceptance to publication
- 2 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,210 / EUR 3,940 / GBP 3,370 / JPY 522,170 | — | — | |
| Publisher website | USD 3,600 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare6 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- ≥ 1
- Reference style
- Numbered, in order of citation
- Highlights
- Required
- Graphical abstract
- Optional
- Cover letter
- Required
Article types accepted15, with length limits
- brief communicationFastTrack Submission Pathway (Pilot Program)Cardiovascular Pathology offers a limited FastTrack submission pathway for selected manuscripts that have previously…main text ≤ 2,000 words
- brief communicationsBrief Communications: The target length is 2000 words or less, with a focused selection of references, Figure(s) or Table(s) needed to convey essential informat…Length not stated
- case reportFastTrack Submission Pathway (Pilot Program)Cardiovascular Pathology offers a limited FastTrack submission pathway for selected manuscripts that have previously…Length not stated
- case reportsCase Reports: Only well worked up case reports about new or interesting entities with a review of the literature will be considered. The target length is 2000 w…Length not stated
- commentariesCommentaries: Present a focused in-depth analysis of topics related to scientific trends, policy, funding, regulatory, educational, and legislative issues, new …Length not stated
- commentaryve issues, new institutes, careers etc. Commentaries should not exceed 3000 words total (including abstract, main text, references and figuremain text ≤ 3,000 words
- editorialFastTrack Submission Pathway (Pilot Program)Cardiovascular Pathology offers a limited FastTrack submission pathway for selected manuscripts that have previously…Length not stated
- editorials and perspectivesEditorials and Perspectives: Editorials and longer perspectives may be invited or unsolicited submissions. The target length is 2000 words or less, with a focus…Length not stated
- full manuscriptsFull Manuscripts: These include original articles and reviews. The target length is 3000 - 4,000 words (12 - 16 double spaced pages).Length not stated
- images in cardiovascular pathologyImages in Cardiovascular Pathology: The target length of the text is no more than 500 words with a maximum of five references and the essential Figure(s).Length not stated
- letterFastTrack Submission Pathway (Pilot Program)Cardiovascular Pathology offers a limited FastTrack submission pathway for selected manuscripts that have previously…Length not stated
- letters to the editormatrix, imaging, methods of analysis). Letters to the Editor: These should be limited to 1500 words, with no more than 5 references and one Figure or Table. Comain text ≤ 1,500 words
- original articleFastTrack Submission Pathway (Pilot Program)Cardiovascular Pathology offers a limited FastTrack submission pathway for selected manuscripts that have previously…Length not stated
- reviewFastTrack Submission Pathway (Pilot Program)Cardiovascular Pathology offers a limited FastTrack submission pathway for selected manuscripts that have previously…Length not stated
- review articleFastTrack Submission Pathway (Pilot Program)Cardiovascular Pathology offers a limited FastTrack submission pathway for selected manuscripts that have previously…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier Inc.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1992
- ISSN
- 1054-8807
- Electronic ISSN
- 1879-1336
- Society / sponsor
- Society for Cardiovascular Pathology
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Cardiovascular Pathology
What CAS zone is Cardiovascular Pathology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Cardiovascular Pathology is in Zone 4 of Medicine, and in Zone 4 of the minor category Cardiac & Cardiovascular Systems / Pathology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Cardiovascular Pathology?
The latest impact factor listed by LetPub is 1.97; CiteScore 3.8, h-index 95.
How long does peer review take at Cardiovascular Pathology?
Based on the dates recorded on 85 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 97 days (interquartile range 65–143 days); authors report an average review time of about 1 month; the community-reported acceptance is “about 25%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Cardiovascular Pathology?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: ≥ 1; Reference style: Numbered, in order of citation; Highlights: Required; Graphical abstract: Optional; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Cardiovascular Pathology based?
Of the 92 board members whose country the journal's board page names, 2 (about 2%) are in mainland China; the countries named most often are United States (55), Italy (13) and Canada (11). Counted from the institutions listed on the board page; for reference only.
Which databases index Cardiovascular Pathology?
According to LetPub and DOAJ records, Cardiovascular Pathology is indexed in SCIE and Scopus.
Is Cardiovascular Pathology open access, and what is the APC?
Cardiovascular Pathology is a hybrid journal. For open-access publication: APC about USD 4,210.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .